Metraipolis › archive › dc_44a613e292e2

Anlotinib-temozolomide combination achieves durable response in multimodal-resistant primary breast angiosarcoma with skull base metastasis and dural… — Europe PMC PMID:42125685

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125685
DOI
10.3389/fonc.2026.1619754
License (as archived)
solo-consultazione
Archived
2026-11-03T04:57:48.124Z
SHA-256 of the archived text
a84e826c38e840f856fd5d96bdf2479c2bad3b61d9320789781a22366c9319da
Stable URL of this page
https://metraipolis.com/documento/dc_44a613e292e2

How to cite

Anlotinib-temozolomide combination achieves durable response in multimodal-resistant primary breast angiosarcoma with skull base metastasis and dural… — Europe PMC PMID:42125685 — Europe PMC (en), https://europepmc.org/article/MED/42125685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44a613e292e2 (Metraipolis archive dc_44a613e292e2, sha256 a84e826c38e840f856fd5d96bdf2479c2bad3b61d9320789781a22366c9319da)
BibTeX
@misc{dc44a613e292e2,
  title = {Anlotinib-temozolomide combination achieves durable response in multimodal-resistant primary breast angiosarcoma with skull base metastasis and dural… — Europe PMC PMID:42125685},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125685},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44a613e292e2; sha256 a84e826c38e840f856fd5d96bdf2479c2bad3b61d9320789781a22366c9319da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125685. Agents can read the archived copy with the MCP tool read_document.